Filing Details
- Accession Number:
- 0001209191-13-003017
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-14 17:08:37
- Reporting Period:
- 2013-01-10
- Filing Date:
- 2013-01-14
- Accepted Time:
- 2013-01-14 17:08:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1292519 | Invivo Therapeutics Holdings Corp. | NVIV | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1503383 | Francis Reynolds | C/O Invivo Therapeutics Holdings Corp. One Kendall Square, Suite B14402 Cambridge MA 02139 | Ceo, Cfo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-01-10 | 2,150 | $2.31 | 14,277,760 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-01-10 | 100 | $2.32 | 14,277,660 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-01-10 | 1,000 | $2.38 | 14,276,660 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-01-10 | 1,000 | $2.40 | 14,275,660 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-01-11 | 1,000 | $2.21 | 14,274,660 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-01-11 | 1,000 | $2.22 | 14,273,660 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-01-11 | 1,250 | $2.23 | 14,272,410 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-01-11 | 1,000 | $2.30 | 14,271,410 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-01-14 | 1,000 | $2.32 | 14,270,410 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-01-14 | 2,000 | $2.35 | 14,268,410 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-01-14 | 1,250 | $2.38 | 14,267,160 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,603 | Indirect | By 401(k) Plan |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2012.
Billionaire Hedge Funds
